Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nutriband Inc WT
(NQ:
NTRBW
)
0.9893
-0.2407 (-19.57%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc WT
< Previous
1
2
3
4
Next >
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
July 14, 2023
Via
ACCESSWIRE
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology
June 23, 2023
Via
ACCESSWIRE
Nutriband to Attend 2023 BIO International Convention
May 10, 2023
Via
ACCESSWIRE
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
April 27, 2023
Via
ACCESSWIRE
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
April 19, 2023
Via
ACCESSWIRE
Nutriband Inc. Commences Trading on Upstream Under NTRB
January 05, 2023
Via
ACCESSWIRE
Nutriband Inc. Will Be the First Company to Dual List on Upstream
December 30, 2022
Via
ACCESSWIRE
Nutriband Approved for Dual Listing on Upstream
December 14, 2022
Via
ACCESSWIRE
Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines
November 08, 2022
Via
ACCESSWIRE
Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
April 04, 2023
Via
ACCESSWIRE
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
March 28, 2023
Via
ACCESSWIRE
Nutriband Inc Joins Webull Corporate Communications Service Platform
March 08, 2023
Via
ACCESSWIRE
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
March 02, 2023
Via
ACCESSWIRE
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register
February 15, 2023
Via
ACCESSWIRE
Nutriband Inc. Reports Revenue Up 113% YoY in Q2
September 08, 2022
Via
ACCESSWIRE
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
January 24, 2023
Via
ACCESSWIRE
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023
December 29, 2022
Via
ACCESSWIRE
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
December 14, 2022
Via
ACCESSWIRE
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3
December 05, 2022
Via
ACCESSWIRE
Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
December 02, 2022
Via
ACCESSWIRE
Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent
December 01, 2022
Via
ACCESSWIRE
Nutriband To Manufacture Fleur Marché-Branded CBD Wellness Patches
October 27, 2022
Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), has signed an exclusive manufacturing agreement with Fleur Marché for its CBD and Botanical Patch lines.
Via
Benzinga
Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement
October 27, 2022
Via
ACCESSWIRE
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology
October 26, 2022
Via
ACCESSWIRE
Nutriband Inc. Invited to Present at the 2023 Transdermal and Microneedle Conference in London on January 23 and 24
October 17, 2022
Via
ACCESSWIRE
Nutriband With Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics for AVERSA(TM) Fentanyl
October 04, 2022
Via
ACCESSWIRE
Nutriband Inc. Announces Application for Dual Listing on Upstream
October 03, 2022
Via
ACCESSWIRE
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
September 15, 2022
Via
ACCESSWIRE
Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split
August 16, 2022
Via
ACCESSWIRE
Nutriband Inc. Details of Seven-for-Six Forward Stock Split
August 10, 2022
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
